APA (7th ed.) Citation

S, B., H, Y., NB, C., EM, A., EA, B., K, T., & O, D. (2025). The pan-immune-inflammation value: A novel independent predictive factor for overall survival in ≥pT2a nonmetastatic renal cell carcinoma. Urologic oncology, 43(6), 395.e7-395.e12. https://doi.org/10.1016/j.urolonc.2024.12.261

Chicago Style (17th ed.) Citation

S, Baykal, Yilmaz H, Cinar NB, Akdas EM, Baynal EA, Teke K, and Dillioglugil O. "The Pan-immune-inflammation Value: A Novel Independent Predictive Factor for Overall Survival in ≥pT2a Nonmetastatic Renal Cell Carcinoma." Urologic Oncology 43, no. 6 (2025): 395.e7-395.e12. https://doi.org/10.1016/j.urolonc.2024.12.261.

MLA (9th ed.) Citation

S, Baykal, et al. "The Pan-immune-inflammation Value: A Novel Independent Predictive Factor for Overall Survival in ≥pT2a Nonmetastatic Renal Cell Carcinoma." Urologic Oncology, vol. 43, no. 6, 2025, pp. 395.e7-395.e12, https://doi.org/10.1016/j.urolonc.2024.12.261.